The Prevelance Rate of Human Cytomegalovirus (HCMV), Epstein-Barr Virus (EBV) and Human Herpes Virus (HHV-6) in a Saliva of the Patient With Periodantitis

• Conditions: Cytomegalovirus; Epstein-Barr Virus Infections; Herpesvirus Infection

• Registration Number: NCT01248598
• Lead Sponsor: Rambam Health Care Campus

Brief Summary

The purpose of this study is to study the prevalence of EBV, HCMV, HHV-6 in saliva and on the toothbrush patient with periodontitis.

Detailed Description

Human cytomegalovirus (HCMV), Epstein-Barr virus (EBV) Human Herpes virus6 (HHV-6)

Study Timeline

• Status Verified: 2010-10
• Study Start: 2010-10
• Study First Submitted: 2010-11-21
• Study First Submitted QC: 2010-11-24
• Last Update Submitted: 2010-11-24
• Study First Posted: 2010-11-25
• Last Update Posted: 2010-11-25

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 10

Inclusion Criteria

• Patient with peridontitis

Exclusion Criteria

• Previous periodontal treatment in last 3 month
• Toothbrushing disability

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The Prevelance Rate of the EBV, HCMV, HHV-6 in saliva	1 year	Check the EBV, HCMV, HHV-6 in saliva by PCR

Secondary Outcome Measures

Name	Time	Method
change outcomes EBV, HCMV, HHV-6 in saliva before and after toothbrushing	1 year	Check the EBV, HCMV, HHV-6 in saliva by RC-PCR before and after toothbrushing

Trial Locations

Locations (1)

Department of Periodontology, School of Graduate Dentistry Rambam Health care campus; 🇮🇱 Haifa, Israel